Segment Information (Tables)
|
12 Months Ended |
Jun. 30, 2026 |
|---|
| Segment Reporting [Abstract] |
|
| Schedule of Segment Reporting Information, by Segment |
The following table presents the Company’s segment revenue and expenses and segment net income for the fiscal years ended June 30, 2026 and 2025 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Year ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
Revenue, net |
|
$ |
182,586 |
|
|
$ |
228,530 |
|
Cost of sales |
|
|
(40,973 |
) |
|
|
(44,864 |
) |
Consultant commissions |
|
|
(72,957 |
) |
|
|
(95,920 |
) |
Consultant incentives, promotions, and recognition |
|
|
(4,137 |
) |
|
|
(6,340 |
) |
Labor and benefits |
|
|
(26,958 |
) |
|
|
(31,216 |
) |
Stock compensation |
|
|
(2,346 |
) |
|
|
(5,702 |
) |
Events |
|
|
(4,065 |
) |
|
|
(3,791 |
) |
Depreciation and amortization |
|
|
(2,773 |
) |
|
|
(3,156 |
) |
Credit card and bank processing fees |
|
|
(5,187 |
) |
|
|
(6,694 |
) |
Other segment items(1) |
|
|
(17,288 |
) |
|
|
(19,035 |
) |
Interest income |
|
|
213 |
|
|
|
466 |
|
Interest expense |
|
|
(49 |
) |
|
|
(35 |
) |
Income tax expense |
|
|
(994 |
) |
|
|
(2,438 |
) |
Net income |
|
$ |
5,072 |
|
|
$ |
9,805 |
|
(1) Other general and administrative expenses include legal, professional services, rent, utilities, and other miscellaneous expenses.
|
| Schedule of Long-lived Assets by Geographic Areas |
The following table presents the Company’s long-lived assets for its most significant geographic markets (in thousands):
|
|
|
|
|
|
|
|
|
|
|
June 30, 2026 |
|
|
June 30, 2025 |
|
United States |
|
$ |
21,393 |
|
|
$ |
18,446 |
|
Foreign: |
|
|
|
|
|
|
Japan |
|
|
1,431 |
|
|
|
1,901 |
|
Other foreign markets |
|
|
280 |
|
|
|
472 |
|
Total foreign markets |
|
|
1,711 |
|
|
|
2,373 |
|
Total long-lived assets |
|
$ |
23,104 |
|
|
$ |
20,819 |
|
|
| Schedule of Revenue Disaggregated by Geographic Regions |
The following table presents the Company’s revenue disaggregated by these markets (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Year ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
United States |
|
$ |
135,404 |
|
|
$ |
178,442 |
|
Foreign: |
|
|
|
|
|
|
Japan |
|
|
24,148 |
|
|
|
25,394 |
|
Other foreign markets |
|
|
23,034 |
|
|
|
24,694 |
|
Total foreign markets |
|
|
47,182 |
|
|
|
50,088 |
|
Total revenue, net |
|
$ |
182,586 |
|
|
$ |
228,530 |
|
|
| Disaggregation of Revenue |
The following table shows revenue by product line for the fiscal years ended June 30, 2026 and 2025 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Year ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
Protandim® product line |
|
$ |
81,989 |
|
|
$ |
95,328 |
|
TrueScience® product line |
|
|
37,853 |
|
|
|
48,712 |
|
LifeVantage® product line |
|
|
32,258 |
|
|
|
61,327 |
|
AXIO® product line |
|
|
15,006 |
|
|
|
15,312 |
|
LoveBiome® product line |
|
|
9,121 |
|
|
|
— |
|
Petandim® product line |
|
|
1,961 |
|
|
|
2,117 |
|
Other(1) |
|
|
4,398 |
|
|
|
5,734 |
|
Total revenue, net |
|
$ |
182,586 |
|
|
$ |
228,530 |
|
(1) Other revenue includes shipping and handling revenue, event related revenue, and other revenues impracticable to allocate to a specific product line.
|